[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hyperthermia Cancer Treatment Systems Market Growth 2023-2029

March 2023 | 100 pages | ID: G8B42977894BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Hyperthermia Cancer Treatment is used to treat cancers. It is divided into local hyperthermia system and whole body hyperthermia system.

LPI (LP Information)' newest research report, the “Hyperthermia Cancer Treatment Systems Industry Forecast” looks at past sales and reviews total world Hyperthermia Cancer Treatment Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperthermia Cancer Treatment Systems sales for 2023 through 2029. With Hyperthermia Cancer Treatment Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperthermia Cancer Treatment Systems industry.

This Insight Report provides a comprehensive analysis of the global Hyperthermia Cancer Treatment Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperthermia Cancer Treatment Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hyperthermia Cancer Treatment Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperthermia Cancer Treatment Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperthermia Cancer Treatment Systems.

The global Hyperthermia Cancer Treatment Systems market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Hyperthermia Cancer Treatment Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Hyperthermia Cancer Treatment Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Hyperthermia Cancer Treatment Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Hyperthermia Cancer Treatment Systems players cover PYREXAR Medical, Celsius43 GmbH, Hydrosun GmbH, Oncotherm Kft., Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd. and Gamida-Cell Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperthermia Cancer Treatment Systems market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Local Hyperthermia System
  • Whole Body Hyperthermia System
Segmentation by application
  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • PYREXAR Medical
  • Celsius43 GmbH
  • Hydrosun GmbH
  • Oncotherm Kft.
  • Andromedic S.r.l.
  • Yamamoto Vinita Co. Ltd
  • Chongqing Haifu Medical Technology Co. Ltd.
  • innoMedicus Ltd.
  • Gamida-Cell Ltd.
  • RanD
  • Gentherm
Key Questions Addressed in this Report

What is the 10-year outlook for the global Hyperthermia Cancer Treatment Systems market?

What factors are driving Hyperthermia Cancer Treatment Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hyperthermia Cancer Treatment Systems market opportunities vary by end market size?

How does Hyperthermia Cancer Treatment Systems break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hyperthermia Cancer Treatment Systems Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Hyperthermia Cancer Treatment Systems by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Hyperthermia Cancer Treatment Systems by Country/Region, 2018, 2022 & 2029
2.2 Hyperthermia Cancer Treatment Systems Segment by Type
  2.2.1 Local Hyperthermia System
  2.2.2 Whole Body Hyperthermia System
2.3 Hyperthermia Cancer Treatment Systems Sales by Type
  2.3.1 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
  2.3.2 Global Hyperthermia Cancer Treatment Systems Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Hyperthermia Cancer Treatment Systems Sale Price by Type (2018-2023)
2.4 Hyperthermia Cancer Treatment Systems Segment by Application
  2.4.1 Breast Cancer
  2.4.2 Liver Cancer
  2.4.3 Soft Tissue Sarcoma
  2.4.4 Head & Neck Tumors
  2.4.5 Prostate Cancer
  2.4.6 Others
2.5 Hyperthermia Cancer Treatment Systems Sales by Application
  2.5.1 Global Hyperthermia Cancer Treatment Systems Sale Market Share by Application (2018-2023)
  2.5.2 Global Hyperthermia Cancer Treatment Systems Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Hyperthermia Cancer Treatment Systems Sale Price by Application (2018-2023)

3 GLOBAL HYPERTHERMIA CANCER TREATMENT SYSTEMS BY COMPANY

3.1 Global Hyperthermia Cancer Treatment Systems Breakdown Data by Company
  3.1.1 Global Hyperthermia Cancer Treatment Systems Annual Sales by Company (2018-2023)
  3.1.2 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Company (2018-2023)
3.2 Global Hyperthermia Cancer Treatment Systems Annual Revenue by Company (2018-2023)
  3.2.1 Global Hyperthermia Cancer Treatment Systems Revenue by Company (2018-2023)
  3.2.2 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Company (2018-2023)
3.3 Global Hyperthermia Cancer Treatment Systems Sale Price by Company
3.4 Key Manufacturers Hyperthermia Cancer Treatment Systems Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Hyperthermia Cancer Treatment Systems Product Location Distribution
  3.4.2 Players Hyperthermia Cancer Treatment Systems Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR HYPERTHERMIA CANCER TREATMENT SYSTEMS BY GEOGRAPHIC REGION

4.1 World Historic Hyperthermia Cancer Treatment Systems Market Size by Geographic Region (2018-2023)
  4.1.1 Global Hyperthermia Cancer Treatment Systems Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Hyperthermia Cancer Treatment Systems Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hyperthermia Cancer Treatment Systems Market Size by Country/Region (2018-2023)
  4.2.1 Global Hyperthermia Cancer Treatment Systems Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Hyperthermia Cancer Treatment Systems Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hyperthermia Cancer Treatment Systems Sales Growth
4.4 APAC Hyperthermia Cancer Treatment Systems Sales Growth
4.5 Europe Hyperthermia Cancer Treatment Systems Sales Growth
4.6 Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Growth

5 AMERICAS

5.1 Americas Hyperthermia Cancer Treatment Systems Sales by Country
  5.1.1 Americas Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023)
  5.1.2 Americas Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023)
5.2 Americas Hyperthermia Cancer Treatment Systems Sales by Type
5.3 Americas Hyperthermia Cancer Treatment Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hyperthermia Cancer Treatment Systems Sales by Region
  6.1.1 APAC Hyperthermia Cancer Treatment Systems Sales by Region (2018-2023)
  6.1.2 APAC Hyperthermia Cancer Treatment Systems Revenue by Region (2018-2023)
6.2 APAC Hyperthermia Cancer Treatment Systems Sales by Type
6.3 APAC Hyperthermia Cancer Treatment Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Hyperthermia Cancer Treatment Systems by Country
  7.1.1 Europe Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023)
  7.1.2 Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023)
7.2 Europe Hyperthermia Cancer Treatment Systems Sales by Type
7.3 Europe Hyperthermia Cancer Treatment Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hyperthermia Cancer Treatment Systems by Country
  8.1.1 Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023)
8.2 Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Type
8.3 Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hyperthermia Cancer Treatment Systems
10.3 Manufacturing Process Analysis of Hyperthermia Cancer Treatment Systems
10.4 Industry Chain Structure of Hyperthermia Cancer Treatment Systems

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Hyperthermia Cancer Treatment Systems Distributors
11.3 Hyperthermia Cancer Treatment Systems Customer

12 WORLD FORECAST REVIEW FOR HYPERTHERMIA CANCER TREATMENT SYSTEMS BY GEOGRAPHIC REGION

12.1 Global Hyperthermia Cancer Treatment Systems Market Size Forecast by Region
  12.1.1 Global Hyperthermia Cancer Treatment Systems Forecast by Region (2024-2029)
  12.1.2 Global Hyperthermia Cancer Treatment Systems Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hyperthermia Cancer Treatment Systems Forecast by Type
12.7 Global Hyperthermia Cancer Treatment Systems Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 PYREXAR Medical
  13.1.1 PYREXAR Medical Company Information
  13.1.2 PYREXAR Medical Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.1.3 PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 PYREXAR Medical Main Business Overview
  13.1.5 PYREXAR Medical Latest Developments
13.2 Celsius43 GmbH
  13.2.1 Celsius43 GmbH Company Information
  13.2.2 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.2.3 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Celsius43 GmbH Main Business Overview
  13.2.5 Celsius43 GmbH Latest Developments
13.3 Hydrosun GmbH
  13.3.1 Hydrosun GmbH Company Information
  13.3.2 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.3.3 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Hydrosun GmbH Main Business Overview
  13.3.5 Hydrosun GmbH Latest Developments
13.4 Oncotherm Kft.
  13.4.1 Oncotherm Kft. Company Information
  13.4.2 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.4.3 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Oncotherm Kft. Main Business Overview
  13.4.5 Oncotherm Kft. Latest Developments
13.5 Andromedic S.r.l.
  13.5.1 Andromedic S.r.l. Company Information
  13.5.2 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.5.3 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Andromedic S.r.l. Main Business Overview
  13.5.5 Andromedic S.r.l. Latest Developments
13.6 Yamamoto Vinita Co. Ltd
  13.6.1 Yamamoto Vinita Co. Ltd Company Information
  13.6.2 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.6.3 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Yamamoto Vinita Co. Ltd Main Business Overview
  13.6.5 Yamamoto Vinita Co. Ltd Latest Developments
13.7 Chongqing Haifu Medical Technology Co. Ltd.
  13.7.1 Chongqing Haifu Medical Technology Co. Ltd. Company Information
  13.7.2 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.7.3 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Chongqing Haifu Medical Technology Co. Ltd. Main Business Overview
  13.7.5 Chongqing Haifu Medical Technology Co. Ltd. Latest Developments
13.8 innoMedicus Ltd.
  13.8.1 innoMedicus Ltd. Company Information
  13.8.2 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.8.3 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 innoMedicus Ltd. Main Business Overview
  13.8.5 innoMedicus Ltd. Latest Developments
13.9 Gamida-Cell Ltd.
  13.9.1 Gamida-Cell Ltd. Company Information
  13.9.2 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.9.3 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Gamida-Cell Ltd. Main Business Overview
  13.9.5 Gamida-Cell Ltd. Latest Developments
13.10 RanD
  13.10.1 RanD Company Information
  13.10.2 RanD Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.10.3 RanD Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 RanD Main Business Overview
  13.10.5 RanD Latest Developments
13.11 Gentherm
  13.11.1 Gentherm Company Information
  13.11.2 Gentherm Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
  13.11.3 Gentherm Hyperthermia Cancer Treatment Systems Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Gentherm Main Business Overview
  13.11.5 Gentherm Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Hyperthermia Cancer Treatment Systems Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hyperthermia Cancer Treatment Systems Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Local Hyperthermia System
Table 4. Major Players of Whole Body Hyperthermia System
Table 5. Global Hyperthermia Cancer Treatment Systems Sales by Type (2018-2023) & (Units)
Table 6. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
Table 7. Global Hyperthermia Cancer Treatment Systems Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2018-2023)
Table 9. Global Hyperthermia Cancer Treatment Systems Sale Price by Type (2018-2023) & (K US$/Unit)
Table 10. Global Hyperthermia Cancer Treatment Systems Sales by Application (2018-2023) & (Units)
Table 11. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2018-2023)
Table 12. Global Hyperthermia Cancer Treatment Systems Revenue by Application (2018-2023)
Table 13. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2018-2023)
Table 14. Global Hyperthermia Cancer Treatment Systems Sale Price by Application (2018-2023) & (K US$/Unit)
Table 15. Global Hyperthermia Cancer Treatment Systems Sales by Company (2018-2023) & (Units)
Table 16. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Company (2018-2023)
Table 17. Global Hyperthermia Cancer Treatment Systems Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Company (2018-2023)
Table 19. Global Hyperthermia Cancer Treatment Systems Sale Price by Company (2018-2023) & (K US$/Unit)
Table 20. Key Manufacturers Hyperthermia Cancer Treatment Systems Producing Area Distribution and Sales Area
Table 21. Players Hyperthermia Cancer Treatment Systems Products Offered
Table 22. Hyperthermia Cancer Treatment Systems Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hyperthermia Cancer Treatment Systems Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Hyperthermia Cancer Treatment Systems Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hyperthermia Cancer Treatment Systems Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hyperthermia Cancer Treatment Systems Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hyperthermia Cancer Treatment Systems Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023) & (Units)
Table 34. Americas Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2018-2023)
Table 35. Americas Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2018-2023)
Table 37. Americas Hyperthermia Cancer Treatment Systems Sales by Type (2018-2023) & (Units)
Table 38. Americas Hyperthermia Cancer Treatment Systems Sales by Application (2018-2023) & (Units)
Table 39. APAC Hyperthermia Cancer Treatment Systems Sales by Region (2018-2023) & (Units)
Table 40. APAC Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2018-2023)
Table 41. APAC Hyperthermia Cancer Treatment Systems Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2018-2023)
Table 43. APAC Hyperthermia Cancer Treatment Systems Sales by Type (2018-2023) & (Units)
Table 44. APAC Hyperthermia Cancer Treatment Systems Sales by Application (2018-2023) & (Units)
Table 45. Europe Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023) & (Units)
Table 46. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2018-2023)
Table 47. Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2018-2023)
Table 49. Europe Hyperthermia Cancer Treatment Systems Sales by Type (2018-2023) & (Units)
Table 50. Europe Hyperthermia Cancer Treatment Systems Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Hyperthermia Cancer Treatment Systems
Table 58. Key Market Challenges & Risks of Hyperthermia Cancer Treatment Systems
Table 59. Key Industry Trends of Hyperthermia Cancer Treatment Systems
Table 60. Hyperthermia Cancer Treatment Systems Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hyperthermia Cancer Treatment Systems Distributors List
Table 63. Hyperthermia Cancer Treatment Systems Customer List
Table 64. Global Hyperthermia Cancer Treatment Systems Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Hyperthermia Cancer Treatment Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hyperthermia Cancer Treatment Systems Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Hyperthermia Cancer Treatment Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hyperthermia Cancer Treatment Systems Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Hyperthermia Cancer Treatment Systems Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hyperthermia Cancer Treatment Systems Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Hyperthermia Cancer Treatment Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hyperthermia Cancer Treatment Systems Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Hyperthermia Cancer Treatment Systems Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hyperthermia Cancer Treatment Systems Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Hyperthermia Cancer Treatment Systems Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. PYREXAR Medical Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 79. PYREXAR Medical Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 80. PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 81. PYREXAR Medical Main Business
Table 82. PYREXAR Medical Latest Developments
Table 83. Celsius43 GmbH Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 84. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 85. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 86. Celsius43 GmbH Main Business
Table 87. Celsius43 GmbH Latest Developments
Table 88. Hydrosun GmbH Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 89. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 90. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 91. Hydrosun GmbH Main Business
Table 92. Hydrosun GmbH Latest Developments
Table 93. Oncotherm Kft. Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 94. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 95. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 96. Oncotherm Kft. Main Business
Table 97. Oncotherm Kft. Latest Developments
Table 98. Andromedic S.r.l. Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 99. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 100. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 101. Andromedic S.r.l. Main Business
Table 102. Andromedic S.r.l. Latest Developments
Table 103. Yamamoto Vinita Co. Ltd Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 104. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 105. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 106. Yamamoto Vinita Co. Ltd Main Business
Table 107. Yamamoto Vinita Co. Ltd Latest Developments
Table 108. Chongqing Haifu Medical Technology Co. Ltd. Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 109. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 110. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 111. Chongqing Haifu Medical Technology Co. Ltd. Main Business
Table 112. Chongqing Haifu Medical Technology Co. Ltd. Latest Developments
Table 113. innoMedicus Ltd. Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 114. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 115. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 116. innoMedicus Ltd. Main Business
Table 117. innoMedicus Ltd. Latest Developments
Table 118. Gamida-Cell Ltd. Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 119. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 120. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 121. Gamida-Cell Ltd. Main Business
Table 122. Gamida-Cell Ltd. Latest Developments
Table 123. RanD Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 124. RanD Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 125. RanD Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 126. RanD Main Business
Table 127. RanD Latest Developments
Table 128. Gentherm Basic Information, Hyperthermia Cancer Treatment Systems Manufacturing Base, Sales Area and Its Competitors
Table 129. Gentherm Hyperthermia Cancer Treatment Systems Product Portfolios and Specifications
Table 130. Gentherm Hyperthermia Cancer Treatment Systems Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2018-2023)
Table 131. Gentherm Main Business
Table 132. Gentherm Latest Developments

LIST OF FIGURES

Figure 1. Picture of Hyperthermia Cancer Treatment Systems
Figure 2. Hyperthermia Cancer Treatment Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hyperthermia Cancer Treatment Systems Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Hyperthermia Cancer Treatment Systems Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hyperthermia Cancer Treatment Systems Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Local Hyperthermia System
Figure 10. Product Picture of Whole Body Hyperthermia System
Figure 11. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type in 2022
Figure 12. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2018-2023)
Figure 13. Hyperthermia Cancer Treatment Systems Consumed in Breast Cancer
Figure 14. Global Hyperthermia Cancer Treatment Systems Market: Breast Cancer (2018-2023) & (Units)
Figure 15. Hyperthermia Cancer Treatment Systems Consumed in Liver Cancer
Figure 16. Global Hyperthermia Cancer Treatment Systems Market: Liver Cancer (2018-2023) & (Units)
Figure 17. Hyperthermia Cancer Treatment Systems Consumed in Soft Tissue Sarcoma
Figure 18. Global Hyperthermia Cancer Treatment Systems Market: Soft Tissue Sarcoma (2018-2023) & (Units)
Figure 19. Hyperthermia Cancer Treatment Systems Consumed in Head & Neck Tumors
Figure 20. Global Hyperthermia Cancer Treatment Systems Market: Head & Neck Tumors (2018-2023) & (Units)
Figure 21. Hyperthermia Cancer Treatment Systems Consumed in Prostate Cancer
Figure 22. Global Hyperthermia Cancer Treatment Systems Market: Prostate Cancer (2018-2023) & (Units)
Figure 23. Hyperthermia Cancer Treatment Systems Consumed in Others
Figure 24. Global Hyperthermia Cancer Treatment Systems Market: Others (2018-2023) & (Units)
Figure 25. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2022)
Figure 26. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application in 2022
Figure 27. Hyperthermia Cancer Treatment Systems Sales Market by Company in 2022 (Units)
Figure 28. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Company in 2022
Figure 29. Hyperthermia Cancer Treatment Systems Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Company in 2022
Figure 31. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Hyperthermia Cancer Treatment Systems Sales 2018-2023 (Units)
Figure 34. Americas Hyperthermia Cancer Treatment Systems Revenue 2018-2023 ($ Millions)
Figure 35. APAC Hyperthermia Cancer Treatment Systems Sales 2018-2023 (Units)
Figure 36. APAC Hyperthermia Cancer Treatment Systems Revenue 2018-2023 ($ Millions)
Figure 37. Europe Hyperthermia Cancer Treatment Systems Sales 2018-2023 (Units)
Figure 38. Europe Hyperthermia Cancer Treatment Systems Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales 2018-2023 (Units)
Figure 40. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue 2018-2023 ($ Millions)
Figure 41. Americas Hyperthermia Cancer Treatment Systems Sales Market Share by Country in 2022
Figure 42. Americas Hyperthermia Cancer Treatment Systems Revenue Market Share by Country in 2022
Figure 43. Americas Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
Figure 44. Americas Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2018-2023)
Figure 45. United States Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Hyperthermia Cancer Treatment Systems Sales Market Share by Region in 2022
Figure 50. APAC Hyperthermia Cancer Treatment Systems Revenue Market Share by Regions in 2022
Figure 51. APAC Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
Figure 52. APAC Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2018-2023)
Figure 53. China Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Country in 2022
Figure 61. Europe Hyperthermia Cancer Treatment Systems Revenue Market Share by Country in 2022
Figure 62. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
Figure 63. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2018-2023)
Figure 64. Germany Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2018-2023)
Figure 73. Egypt Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Hyperthermia Cancer Treatment Systems Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Hyperthermia Cancer Treatment Systems in 2022
Figure 79. Manufacturing Process Analysis of Hyperthermia Cancer Treatment Systems
Figure 80. Industry Chain Structure of Hyperthermia Cancer Treatment Systems
Figure 81. Channels of Distribution
Figure 82. Global Hyperthermia Cancer Treatment Systems Sales Market Forecast by Region (2024-2029)
Figure 83. Global Hyperthermia Cancer Treatment Systems Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Hyperthermia Cancer Treatment Systems Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Hyperthermia Cancer Treatment Systems Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Hyperthermia Cancer Treatment Systems Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Hyperthermia Cancer Treatment Systems Revenue Market Share Forecast by Application (2024-2029)


More Publications